Business Description
Genomics BioSci & Tech Co Ltd
ISIN : TW0004195003
Description
Genomics BioSci & Tech Co Ltd is a Taiwan based commercial genome sequencing company formed to develop medical genetic testing. The services of the company include Sanger sequence service, Synthesis Service and Genomic Service.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.93 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | -2.3 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.38 | |||||
| Beneish M-Score | -2.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.4 | |||||
| 3-Year FCF Growth Rate | -48.3 | |||||
| 3-Year Book Growth Rate | -1.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.07 | |||||
| 9-Day RSI | 41.51 | |||||
| 14-Day RSI | 45.7 | |||||
| 6-1 Month Momentum % | -4.83 | |||||
| 12-1 Month Momentum % | -8.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.23 | |||||
| Quick Ratio | 2.81 | |||||
| Cash Ratio | 1.81 | |||||
| Days Inventory | 74.81 | |||||
| Days Sales Outstanding | 97.56 | |||||
| Days Payable | 44.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.53 | |||||
| 3-Year Dividend Growth Rate | -55.5 | |||||
| Forward Dividend Yield % | 0.53 | |||||
| 5-Year Yield-on-Cost % | 0.53 | |||||
| 3-Year Average Share Buyback Ratio | -5.9 | |||||
| Shareholder Yield % | -15.38 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.27 | |||||
| Operating Margin % | -21.46 | |||||
| Net Margin % | -42.43 | |||||
| FCF Margin % | -62.45 | |||||
| ROE % | -20.92 | |||||
| ROA % | -14.92 | |||||
| ROIC % | -11.22 | |||||
| ROC (Joel Greenblatt) % | -30.87 | |||||
| ROCE % | -16.57 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.41 | |||||
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 1.8 | |||||
| EV-to-EBIT | -8.55 | |||||
| EV-to-EBITDA | -11.32 | |||||
| EV-to-Revenue | 3.52 | |||||
| EV-to-FCF | -5.76 | |||||
| Price-to-Median-PS-Value | 1.26 | |||||
| Price-to-Net-Current-Asset-Value | 13.29 | |||||
| Earnings Yield (Greenblatt) % | -11.69 | |||||
| FCF Yield % | -17.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomics BioSci & Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 396.142 | ||
| EPS (TTM) (NT$) | -2.36 | ||
| Beta | 0.24 | ||
| Volatility % | 24.29 | ||
| 14-Day RSI | 45.7 | ||
| 14-Day ATR (NT$) | 0.513939 | ||
| 20-Day SMA (NT$) | 19.28 | ||
| 12-1 Month Momentum % | -8.66 | ||
| 52-Week Range (NT$) | 17.6 - 26.078431 | ||
| Shares Outstanding (Mil) | 72.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomics BioSci & Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomics BioSci & Tech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genomics BioSci & Tech Co Ltd Frequently Asked Questions
What is Genomics BioSci & Tech Co Ltd(ROCO:4195)'s stock price today?
The current price of ROCO:4195 is NT$19.00. The 52 week high of ROCO:4195 is NT$26.08 and 52 week low is NT$17.60.
When is next earnings date of Genomics BioSci & Tech Co Ltd(ROCO:4195)?
The next earnings date of Genomics BioSci & Tech Co Ltd(ROCO:4195) is .
Does Genomics BioSci & Tech Co Ltd(ROCO:4195) pay dividends? If so, how much?
The Dividend Yield %  of Genomics BioSci & Tech Co Ltd(ROCO:4195) is 0.53% (As of Today), Highest Dividend Payout Ratio of Genomics BioSci & Tech Co Ltd(ROCO:4195) was 18.06. The lowest was 18.06. And the median was 18.06. The  Forward Dividend Yield % of Genomics BioSci & Tech Co Ltd(ROCO:4195) is 0.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers